Physician profile
Robert S Cohen
NPI 1952395790
$2,307.90
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,263 · 2020: $19.95 · 2024: $24.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $618.88 | 2019 | |
| Mallinckrodt Enterprises LLC | $572.79 | 2019 | |
| Alexion Pharmaceuticals, INC. | $245.00 | 2019 | |
| Amgen INC. | $221.26 | 2019 | |
| Vifor Pharma, INC. | $145.57 | 2019 | |
| Opko Pharmaceuticals, LLC | $133.90 | 2019 | |
| Fresenius USA Marketing, INC. | $122.73 | 2019 | |
| Abbott Laboratories | $65.82 | 2019-2024 | Absolute Pro |
| Akebia Therapeutics INC | $60.40 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.10 | 2019 | |
| Boston Scientific Corporation | $19.95 | 2020 | |
| Daiichi Sankyo INC. | $14.64 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.